The Butantan Biological Institute will make a request to federal health regulator Anvisa to carry out new clinical trials using the CoronaVac Covid-19 vaccine, using an updated version of the immunizer which is hoped to be more effective against the Gamma coronavirus variant.
According to prior studies, the ‘new’ CoronaVac is more effective against a variety of new mutations, which have already become dominant across Latin America. Once new tests are approved, Butantan’s plan is to issue third doses of the vaccine as booster shots, a strategy tested by Cuba with its Abdala vaccine.
Butantan experts say the new version of the vaccine provides a solid immune response against the Delta coronavirus variant, which researchers believe is more contagious and more lethal.
The relationship between farmers and the Luiz Inácio Lula da Silva administration is by no…
Pelé, Ronaldo, Zico, Marta … All of Brazil’s truly immortal sporting icons are footballers, that…
Speaking before a Senate hearing on Tuesday, Chief of Staff Rui Costa admitted that Brazil…
New job market data from the Brazilian Institute of Geography and Statistics (IBGE) show the…
Brazil officially had 5.83 million domestic workers in 2022 — almost the entire population of…
Brazil’s Ministry of Health this month announced a purchase of 12.5 million doses of Moderna’s…